MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq:GERN) today announced that Corning Incorporated (NYSE:GLW) has launched the Synthemax™ surface, a new synthetic matrix for growing human embryonic stem cells (hESCs), developed under a collaboration and license agreement between the two companies.
